{
      "ptx_code": "PTX181",
      "chem_name": "Sulfamethoxazole",
      "casrn": "723-46-6",
      "dtxsid": "DTXSID8026064",
      "smiles": "CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1",
      "inchikey": "JLKIGFTWXXRPMT-UHFFFAOYSA-N",
      "label": "PTX181 | Sulfamethoxazole",
      "pubchem_cid": "5329",
      "drugbank_id": "DB01015",
      "use_class": "Pharmaceutical",
      "tox_class": "Hepatotoxicity; Nephrotoxicity",
      "formula": "C10H11N3O3S",
      "chem_name_user": "Sulfamethoxazole",
      "mw_g_mol": "253.28",
      "solubility_h2o_mol_liter": "2.11e-03",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.72e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.15",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "5.68",
      "pka_base": "1.85",
      "source_pka": "UFZ; Sirius T3; Qiang et al. 2004",
      "log_kow_liter_liter": "0.89",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "0.35",
      "source_dlipw": "Escher et al. 2017",
      "freely_dissolved_fraction": "0.93",
      "density_kg_liter": "1.44",
      "source_density": "COMPTOX",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "167.5; 168.0; 171.5",
      "source_melting_point": "CompTox (SynQuest Labs (Chemical company; Jean-Claude Bradley Open Melting Point Dataset; Jean-Claude Bradley Open Melting Point Dataset)",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "4784.27",
      "baseline_dmagna": "1755.06",
      "baseline_celegans": "3889.10",
      "baseline_xlaevis": "861.17",
      "baseline_dmelanogaster": "15797.60",
      "baseline_cells": "0.01",
      "baseline_cells_generic_micromole_liter_free_ec10": "0.01",
      "moa_drugbank": "Sulfamethoxazole is a sulfonamide that inhibits bacterial dihydrofolic acid synthesis due to its structural similarity to an endogenous substrate, para-aminobenzoic acid (PABA).[A187343,A187364] Most bacteria meet their need for folic acid by synthesizing it from PABA, as opposed to Animalia that require exogenous folic acid sources.[L11851] Sulfamethoxazole competitively inhibits dihydropteroate synthase, the enzyme responsible for bacterial conversion of PABA to dihydrofolic acid.[A112882] Inhibition of this pathway prevents the synthesis of tetrahydrofolate and, ultimately, the synthesis of bacterial purines and DNA, resulting in a bacteriostatic effect.[A187340]",
      "protein_binding": "Sulfamethoxazole is approximately 70% bound to plasma proteins,[L11830] primarily to albumin.[L11851]",
      "moa_t3db": "",
      "aop": [],
      "targets": []
}